CN Stock MarketDetailed Quotes

300016 Beijing Beilu Pharmaceutical

Watchlist
  • 5.92
  • -0.19-3.11%
Market Closed Jan 3 15:00 CST
2.91BMarket Cap-59.20P/E (TTM)

Beijing Beilu Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
12.30%729.72M
8.20%473.93M
10.35%207.51M
16.30%890.72M
16.60%649.82M
24.70%438.03M
2.23%188.04M
-10.93%765.88M
-18.14%557.31M
-34.38%351.26M
Operating revenue
12.30%729.72M
8.20%473.93M
10.35%207.51M
16.30%890.72M
16.60%649.82M
24.70%438.03M
2.23%188.04M
-10.93%765.88M
-18.14%557.31M
-34.38%351.26M
Other operating revenue
----
313.48%3.57M
----
44.96%6.42M
----
-58.00%864.44K
----
44.69%4.43M
----
89.79%2.06M
Total operating cost
4.51%705.51M
1.74%452.06M
5.58%191.5M
19.91%947.67M
24.16%675.05M
33.75%444.33M
21.20%181.38M
2.25%790.34M
-4.24%543.7M
-20.39%332.2M
Operating cost
9.86%364.6M
5.67%233.59M
-6.45%92.11M
38.15%472.01M
44.72%331.88M
55.04%221.05M
34.66%98.45M
5.31%341.66M
-4.61%229.32M
-27.26%142.58M
Operating tax surcharges
8.63%9.24M
8.74%6.17M
49.61%2.69M
-10.15%10.29M
10.22%8.51M
7.29%5.68M
-25.30%1.8M
11.04%11.45M
1.78%7.72M
-18.04%5.29M
Operating expense
14.98%177.55M
10.50%112.93M
52.54%52.05M
3.08%217.05M
4.44%154.42M
16.57%102.2M
-12.18%34.12M
-26.03%210.56M
-30.29%147.86M
-37.22%87.67M
Administration expense
9.95%61.03M
6.66%39.15M
1.25%18.05M
-4.61%81.74M
-15.07%55.51M
-5.26%36.71M
-6.55%17.82M
8.54%85.69M
19.13%65.36M
3.86%38.75M
Financial expense
3.99%39.91M
-0.93%24.77M
4.78%12.72M
5.43%44.26M
32.98%38.38M
38.91%25M
38.93%12.14M
53.22%41.98M
40.07%28.86M
32.58%18M
-Interest expense (Financial expense)
11.00%44.03M
10.94%28.16M
10.00%13.76M
11.53%53.14M
12.81%39.66M
11.11%25.38M
13.07%12.51M
7.82%47.64M
8.47%35.16M
5.55%22.84M
-Interest Income (Financial expense)
32.92%-4.48M
21.61%-3.39M
35.24%-1.68M
-39.34%-11.82M
-11.01%-6.68M
-7.43%-4.32M
-37.90%-2.6M
35.71%-8.48M
39.39%-6.02M
37.36%-4.02M
Research and development
-38.42%53.17M
-33.98%35.45M
-18.50%13.89M
23.55%122.33M
33.70%86.35M
34.51%53.7M
128.07%17.04M
109.64%99.01M
100.45%64.58M
64.21%39.92M
Credit Impairment Loss
213.47%1.99M
133.17%566.92K
143.39%879.63K
-598.64%-3.83M
-226.30%-1.76M
-202.20%-1.71M
-64.45%361.41K
-42.19%768.89K
96.06%1.39M
140.56%1.67M
Asset Impairment Loss
-0.86%-3.78M
6.10%-3.22M
-34.34%-834.08K
-89.72%-45.18M
-25.60%-3.75M
-215.35%-3.43M
66.55%-620.86K
-572.32%-23.81M
-108.25%-2.99M
-0.34%-1.09M
Other net revenue
-108.44%-1.31M
-115.10%-1.27M
-103.84%-139.04K
-489.15%-43.49M
-45.72%15.49M
-55.68%8.41M
-36.81%3.62M
-72.23%11.18M
1.60%28.54M
105.49%18.98M
Fair value change income
-246.37%-13.45M
-236.13%-8.91M
-229.90%-3.68M
-153.19%-13.96M
-56.54%9.19M
-49.60%6.54M
-43.54%2.84M
88.78%26.24M
124.23%21.15M
124.64%12.98M
Invest income
27.39%5.75M
4.16%3.78M
530.08%849.8K
205.20%5.99M
264.67%4.51M
192.70%3.63M
-150.05%-197.59K
-143.39%-5.7M
-160.91%-2.74M
-175.95%-3.91M
-Including: Investment income associates
-108.82%-149.73K
-70.70%330.16K
53.16%-371.13K
117.23%1.95M
185.91%1.7M
152.80%1.13M
-10,627.56%-792.28K
-585.00%-11.35M
-240.81%-1.98M
-245.41%-2.13M
Asset deal income
-99.79%1.82K
-99.79%1.82K
--1.82K
801.04%894.31K
772.62%866.11K
--866.11K
----
-21.32%99.25K
-21.32%99.25K
----
Other revenue
27.39%8.19M
158.83%6.51M
112.50%2.65M
-7.27%12.59M
-44.70%6.43M
-73.03%2.52M
7.54%1.25M
-11.30%13.58M
-21.23%11.62M
165.57%9.33M
Operating profit
335.24%22.9M
874.88%20.6M
54.28%15.86M
-656.17%-100.44M
-123.10%-9.74M
-94.44%2.11M
-74.30%10.28M
-110.44%-13.28M
-70.14%42.15M
-70.10%38.04M
Add:Non operating Income
-62.67%566.85K
-93.32%100.53K
92.12%49.32K
386.71%1.77M
3,896.51%1.52M
3,858.83%1.5M
25,570.58%25.67K
31.74%363.23K
-85.89%37.99K
-78.10%37.99K
Less:Non operating expense
71.99%1.4M
-51.01%266.21K
-88.33%3.71K
34.81%2.48M
-41.90%811.19K
-29.80%543.44K
-94.07%31.83K
-63.84%1.84M
-67.83%1.4M
-77.36%774.19K
Total profit
344.49%22.08M
564.83%20.44M
54.82%15.91M
-585.25%-101.15M
-122.14%-9.03M
-91.76%3.07M
-73.97%10.28M
-112.06%-14.76M
-70.24%40.79M
-69.91%37.3M
Less:Income tax cost
163.79%3.07M
378.17%5.24M
4,586.93%4.29M
-75.80%-17.95M
-253.02%-4.81M
-164.74%-1.88M
-98.05%91.47K
-184.67%-10.21M
-109.09%-1.36M
-80.19%2.91M
Net profit
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
-85.59%4.96M
-70.72%10.18M
-104.12%-4.55M
-65.47%42.15M
-68.53%34.4M
Net profit from continuing operation
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
-85.59%4.96M
-70.72%10.18M
-104.12%-4.55M
-65.47%42.15M
-68.53%34.4M
Less:Minority Profit
12.43%-5.39M
6.54%-4.34M
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
17.80%-4.65M
46.69%-2.39M
-4.02%-15.83M
-70.25%-13.06M
21.35%-5.65M
Net profit of parent company owners
1,156.34%24.39M
103.52%19.54M
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
-76.02%9.6M
-67.97%12.58M
-91.01%11.28M
-57.44%55.21M
-65.62%40.05M
Earning per share
Basic earning per share
1,142.50%0.0497
100.00%0.04
-8.20%0.0235
-850.00%-0.15
-96.44%0.004
-75.00%0.02
-68.00%0.0256
-92.31%0.02
-57.60%0.1125
-66.67%0.08
Diluted earning per share
86.73%0.0999
40.00%0.07
-0.95%0.0415
-187.50%-0.07
-64.17%0.0535
-54.55%0.05
-49.58%0.0419
-71.43%0.08
-47.85%0.1493
-56.00%0.11
Other composite income
Total composite income
550.92%19M
206.69%15.2M
14.11%11.62M
-1,728.99%-83.2M
-110.00%-4.21M
-85.59%4.96M
-70.72%10.18M
-104.15%-4.55M
-65.45%42.15M
-68.52%34.4M
Total composite income of parent company owners
1,156.34%24.39M
103.52%19.54M
-8.35%11.53M
-735.92%-71.76M
-96.48%1.94M
-76.02%9.6M
-67.97%12.58M
-90.96%11.28M
-57.42%55.21M
-65.61%40.05M
Total composite income of minority owners
12.43%-5.39M
6.54%-4.34M
103.97%95.08K
27.72%-11.44M
52.87%-6.16M
17.80%-4.65M
46.69%-2.39M
-4.02%-15.83M
-70.25%-13.06M
21.35%-5.65M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 12.30%729.72M8.20%473.93M10.35%207.51M16.30%890.72M16.60%649.82M24.70%438.03M2.23%188.04M-10.93%765.88M-18.14%557.31M-34.38%351.26M
Operating revenue 12.30%729.72M8.20%473.93M10.35%207.51M16.30%890.72M16.60%649.82M24.70%438.03M2.23%188.04M-10.93%765.88M-18.14%557.31M-34.38%351.26M
Other operating revenue ----313.48%3.57M----44.96%6.42M-----58.00%864.44K----44.69%4.43M----89.79%2.06M
Total operating cost 4.51%705.51M1.74%452.06M5.58%191.5M19.91%947.67M24.16%675.05M33.75%444.33M21.20%181.38M2.25%790.34M-4.24%543.7M-20.39%332.2M
Operating cost 9.86%364.6M5.67%233.59M-6.45%92.11M38.15%472.01M44.72%331.88M55.04%221.05M34.66%98.45M5.31%341.66M-4.61%229.32M-27.26%142.58M
Operating tax surcharges 8.63%9.24M8.74%6.17M49.61%2.69M-10.15%10.29M10.22%8.51M7.29%5.68M-25.30%1.8M11.04%11.45M1.78%7.72M-18.04%5.29M
Operating expense 14.98%177.55M10.50%112.93M52.54%52.05M3.08%217.05M4.44%154.42M16.57%102.2M-12.18%34.12M-26.03%210.56M-30.29%147.86M-37.22%87.67M
Administration expense 9.95%61.03M6.66%39.15M1.25%18.05M-4.61%81.74M-15.07%55.51M-5.26%36.71M-6.55%17.82M8.54%85.69M19.13%65.36M3.86%38.75M
Financial expense 3.99%39.91M-0.93%24.77M4.78%12.72M5.43%44.26M32.98%38.38M38.91%25M38.93%12.14M53.22%41.98M40.07%28.86M32.58%18M
-Interest expense (Financial expense) 11.00%44.03M10.94%28.16M10.00%13.76M11.53%53.14M12.81%39.66M11.11%25.38M13.07%12.51M7.82%47.64M8.47%35.16M5.55%22.84M
-Interest Income (Financial expense) 32.92%-4.48M21.61%-3.39M35.24%-1.68M-39.34%-11.82M-11.01%-6.68M-7.43%-4.32M-37.90%-2.6M35.71%-8.48M39.39%-6.02M37.36%-4.02M
Research and development -38.42%53.17M-33.98%35.45M-18.50%13.89M23.55%122.33M33.70%86.35M34.51%53.7M128.07%17.04M109.64%99.01M100.45%64.58M64.21%39.92M
Credit Impairment Loss 213.47%1.99M133.17%566.92K143.39%879.63K-598.64%-3.83M-226.30%-1.76M-202.20%-1.71M-64.45%361.41K-42.19%768.89K96.06%1.39M140.56%1.67M
Asset Impairment Loss -0.86%-3.78M6.10%-3.22M-34.34%-834.08K-89.72%-45.18M-25.60%-3.75M-215.35%-3.43M66.55%-620.86K-572.32%-23.81M-108.25%-2.99M-0.34%-1.09M
Other net revenue -108.44%-1.31M-115.10%-1.27M-103.84%-139.04K-489.15%-43.49M-45.72%15.49M-55.68%8.41M-36.81%3.62M-72.23%11.18M1.60%28.54M105.49%18.98M
Fair value change income -246.37%-13.45M-236.13%-8.91M-229.90%-3.68M-153.19%-13.96M-56.54%9.19M-49.60%6.54M-43.54%2.84M88.78%26.24M124.23%21.15M124.64%12.98M
Invest income 27.39%5.75M4.16%3.78M530.08%849.8K205.20%5.99M264.67%4.51M192.70%3.63M-150.05%-197.59K-143.39%-5.7M-160.91%-2.74M-175.95%-3.91M
-Including: Investment income associates -108.82%-149.73K-70.70%330.16K53.16%-371.13K117.23%1.95M185.91%1.7M152.80%1.13M-10,627.56%-792.28K-585.00%-11.35M-240.81%-1.98M-245.41%-2.13M
Asset deal income -99.79%1.82K-99.79%1.82K--1.82K801.04%894.31K772.62%866.11K--866.11K-----21.32%99.25K-21.32%99.25K----
Other revenue 27.39%8.19M158.83%6.51M112.50%2.65M-7.27%12.59M-44.70%6.43M-73.03%2.52M7.54%1.25M-11.30%13.58M-21.23%11.62M165.57%9.33M
Operating profit 335.24%22.9M874.88%20.6M54.28%15.86M-656.17%-100.44M-123.10%-9.74M-94.44%2.11M-74.30%10.28M-110.44%-13.28M-70.14%42.15M-70.10%38.04M
Add:Non operating Income -62.67%566.85K-93.32%100.53K92.12%49.32K386.71%1.77M3,896.51%1.52M3,858.83%1.5M25,570.58%25.67K31.74%363.23K-85.89%37.99K-78.10%37.99K
Less:Non operating expense 71.99%1.4M-51.01%266.21K-88.33%3.71K34.81%2.48M-41.90%811.19K-29.80%543.44K-94.07%31.83K-63.84%1.84M-67.83%1.4M-77.36%774.19K
Total profit 344.49%22.08M564.83%20.44M54.82%15.91M-585.25%-101.15M-122.14%-9.03M-91.76%3.07M-73.97%10.28M-112.06%-14.76M-70.24%40.79M-69.91%37.3M
Less:Income tax cost 163.79%3.07M378.17%5.24M4,586.93%4.29M-75.80%-17.95M-253.02%-4.81M-164.74%-1.88M-98.05%91.47K-184.67%-10.21M-109.09%-1.36M-80.19%2.91M
Net profit 550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M-85.59%4.96M-70.72%10.18M-104.12%-4.55M-65.47%42.15M-68.53%34.4M
Net profit from continuing operation 550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M-85.59%4.96M-70.72%10.18M-104.12%-4.55M-65.47%42.15M-68.53%34.4M
Less:Minority Profit 12.43%-5.39M6.54%-4.34M103.97%95.08K27.72%-11.44M52.87%-6.16M17.80%-4.65M46.69%-2.39M-4.02%-15.83M-70.25%-13.06M21.35%-5.65M
Net profit of parent company owners 1,156.34%24.39M103.52%19.54M-8.35%11.53M-735.92%-71.76M-96.48%1.94M-76.02%9.6M-67.97%12.58M-91.01%11.28M-57.44%55.21M-65.62%40.05M
Earning per share
Basic earning per share 1,142.50%0.0497100.00%0.04-8.20%0.0235-850.00%-0.15-96.44%0.004-75.00%0.02-68.00%0.0256-92.31%0.02-57.60%0.1125-66.67%0.08
Diluted earning per share 86.73%0.099940.00%0.07-0.95%0.0415-187.50%-0.07-64.17%0.0535-54.55%0.05-49.58%0.0419-71.43%0.08-47.85%0.1493-56.00%0.11
Other composite income
Total composite income 550.92%19M206.69%15.2M14.11%11.62M-1,728.99%-83.2M-110.00%-4.21M-85.59%4.96M-70.72%10.18M-104.15%-4.55M-65.45%42.15M-68.52%34.4M
Total composite income of parent company owners 1,156.34%24.39M103.52%19.54M-8.35%11.53M-735.92%-71.76M-96.48%1.94M-76.02%9.6M-67.97%12.58M-90.96%11.28M-57.42%55.21M-65.61%40.05M
Total composite income of minority owners 12.43%-5.39M6.54%-4.34M103.97%95.08K27.72%-11.44M52.87%-6.16M17.80%-4.65M46.69%-2.39M-4.02%-15.83M-70.25%-13.06M21.35%-5.65M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.